Program

The 2024 Workshop Program is under development.
Program is subject to change. 

FRIDAY , JULY 26

Workshop Pretest available, to be completed by 1 p.m. on Sunday, July 28

SUNDAY, JULY 28

Registration
1:30 pm-5:30 pm

Faculty Meeting
4:30 pm-5:15 pm

Welcome/Overview
5:30 pm-5:45 pm
Manuel Hidalgo, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York
Wendy B. London, Dana-Farber Cancer Institute and Boston Children’s Hospital, Boston, Massachusetts
Julie M. Vose, University of Nebraska Medical Center, Omaha, Nebraska

Opening Keynote Lecture
Session Chair: Manuel Hidalgo, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York
5:45 pm-6:30 pm

  • Career Development Opportunities: The Government Can Help
    Oliver Bogler, National Cancer Institute, Rockville, Maryland

Dinner/Protocol Development Group Session 1
6:30 pm-8:30 pm

MONDAY, JULY 29

Breakfast
7:00 am-8:00 am

Lecture Session 1
8:00 am-9:45 am

  • Answering Important Questions: From Hypothesis to Analysis
  • Phase I Trial Questions
  • Phase I Trial Designs

Questions / Panel Discussion

Break
9:45 am-10:00 am

Lecture Session 2
10:00 am-12:00 pm

  • Phase II Trial Questions/Objectives
  • Phase II Trial Designs
  • Drug Combination Trials
  • Multimodality Trials

Questions / Panel Discussion

Lunch
12:00 pm-1:30 pm

Protocol Development Group Session 2
1:30 pm-4:00 pm

Independent Study Time
4:00 pm-7:00 pm

Personalized Mentoring Session 1 (Biostatisticians and Patient Advocates; prescheduled appointments)
4:15 pm-6:30 pm

ASSIGNMENT DUE: PROTOCOL TEMPLATE
7:00 pm

Dinner
7:00 pm-9:00 pm

TUESDAY, JULY 30

Breakfast
7 am-8 am

Lecture Session 3
8:00 am-9:40 am

  • Feasibility and Reproducibility in Biomarker Studies
  • Incorporation of Biological Correlative Studies into Early Clinical Trials
  • Statistical Aspects of Correlative Studies

Questions / Panel Discussion

Break
9:40 am-10:00 am

Lecture Session 4
10:00 am-11:40 am

  • Imaging in the Era of Targeted Therapy and Immunotherapy
  • Special Considerations in the Design of Immunotherapy Studies
  • Barriers to Accrual and How to Overcome Them

Questions / Panel Discussion

Lunch
11:40 am-12:45 pm

Protocol Development Group Session 3
12:45 pm-3:45 pm

Independent Study Time
3:45 pm-7:00 pm

Personalized Mentoring Session 2: Protocol Related Questions
3:45 pm-6:00 pm
Room locations noted on signup sheets
(Signup sheets will be available during the morning break.)

Dinner (Grab and Go)
5:00 pm-7:00 pm

ASSIGNMENT DUE: STATISTICAL DESIGN
7:00 pm

WEDNESDAY, JULY 31

Breakfast
7:00 am-8:00 am

Small Group Discussion Sessions 1-3
8:00 am-9:00 am

  • Elements of Artificial Intelligence
  • Symptom Management, Patient Reported Outcomes, and Quality of Life
  • Phase III Trials

Break
9:00 am-9:15 am

Small Group Discussion Sessions 4-6
9:15 am-10:15 am

  • Navigating the National Clinical Trials Network
  • Laboratory Correlates, ctDNA, and Liquid Biopsy

Break / Group Photo
10:15 am-10:45 am

Small Group Discussion Sessions 7-9
10:45 am-11:45 am

  • Defining, Identifying, and Knowing Your Trial’s Clinical Endpoints
  • Understanding the Regulatory Process
  • Large-Scale Genomic Analysis: Bench to Bedside

Lunch
11:45 am-12:30 pm

Protocol Development Group Session 4
12:30 pm-2:30 pm

Independent Study Time/Dinner on Own
2:30 pm-7:00 pm

Personalized Mentoring Session 3: Protocol Related Questions
3:45 pm-6:00 pm
Room locations noted on signup sheets
(Signup sheets will be available during the morning break.)

ASSIGNMENT DUE: PROTOCOL DRAFTS
7:00 pm

THURSDAY, AUGUST 1

Breakfast
7:00 am-8:00 am

Lecture Session 5
8:00 am-9:40 am

  • You’re in Charge: Investigator Responsibilities
  • How to Pay for Your Trial
  • Everything You Need to Know About Clinical Trial Ethics and Informed Consent

Questions / Panel Discussion

Break
9:40 am-9:55 am

Lecture Session 6
9:55 am-11:35 am

  • Data Collection: It’s All In the Data
  • Inclusivity in Clinical Trials
  • Community Engagement

Questions / Panel Discussion

Break
11:35 am-11:45 am

Keynote Lecture
11:45 am-12:35 pm

Lunch
12:35 pm-1:30 pm

Protocol Development Group Session 5
1:30 pm-3:00 pm

Independent Study Time/Dinner on Own
3:00 pm-7:00 pm

Personalized Mentoring Session 4: Informed Consent/Protocol Related Questions, and Career Guidance
3:15pm-5:30 pm
Room locations noted on signup sheets
(Signup sheets will be available during the morning breaks.)

Optional Networking Session: Women in Hematology/Oncology
5:30 pm-6:30 pm

ASSIGNMENT DUE: INFORMED CONSENT DOCUMENTS
7:00 pm

FRIDAY, AUGUST 2

Breakfast
7:00 am-8:30 am

Faculty Meeting (Faculty Only)
7:30 am-8:30 am

Optional Career Sessions
(Exact topics to be determined based on accepted applicant interests, topics shown below are examples from past Workshops)
8:30 am-9:30 am

  • Collaborating and Networking
  • Work-Life Balance
  • Career Transition and Advancement Tips

Break
9:30 am-9:45 am

Lecture Session 7
9:45 am-11:15 am

  • Successful Grantsmanship
  • Reporting and Presenting Results

Questions / Panel Discussion

Break
11:15 am-11:30 pm

Protocol Development Group Session 6
11:30 am-1:00 pm

Lunch (Boxed)
1:00 pm-2:00 pm

Administration of Post-test
1:00 pm-4:00 pm

Independent Study Time
1:00 pm-7:00 pm

ASSIGNMENT DUE: FINAL PROTOCOLS, INFORMED CONSENT FORMS, and ALL WORKSHOP EVALUATIONS
7:00 pm

Closing Reception / Banquet / Dance
7:00 pm-11:00 pm

SATURDAY, AUGUST 3

Departure (on own)